Erythroid differentiation is accompanied by dramatic alterations in morphology and membrane mechanical properties resulting, in large part, from reorganization ofthe membrane skeletal protein network. The 80-kD protein 4
Introduction
During terminal differentiation, erythroid progenitors undergo multiple structural changes involving cytoplasmic organelles, Received for publication 8 July 1991 and in revisedform 1O August 1992. skeletal and cytoskeletal proteins, and cell surface components. Although specific aspects oferythroid maturation and remodeling (such as transferrin receptor down regulation and asynchronous synthesis ofmembrane proteins) have been studied, many unanswered questions remain (1) (2) (3) (4) (5) (6) . We have previously reported that a dramatic change in membrane mechanical properties occurs during the final stages of erythroid development, the 72-h period during which the reticulocyte matures into a red cell. (7) We found that young, immature reticulocyte membranes were markedly less deformable and mechanically more unstable compared to membranes of mature red cells. Since membrane skeletal protein organization regulates the membrane properties of deformability and stability (8) (9) (10) , we interpreted these data as signifying a marked reorganization of the membrane skeleton during reticulocyte maturation.
The erythroid membrane skeleton is a latticework composed of spectrin, actin, ankyrin, tropomyosin, adducin, and proteins 4.1 and 4.9, which underlies the lipid bilayer and is associated with it through protein-protein and protein-lipid interactions. Together, the proteins comprising this lattice play a crucial role in supporting the bilayer and in determining the membrane mechanical properties of deformability and stability (8) (9) (10) . The 80-kD erythrocyte protein 4.1 is an important organizational component of the membrane skeleton because it participates in horizontal associations within the skeletal network by facilitating spectrin-actin interactions and it participates in vertical associations between the network and the lipid bilayer by binding to the cytoplasmic domain of the integral proteins, glycophorin C and band 3 (11) (12) (13) (14) (15) (16) . Recently, it has been recognized that multiple structural isoforms of protein 4.1 are encoded by a single gene via alternative pre-mRNA splicing (17) (18) (19) (20) . Included in this isoform family are proteins that vary from one another in the functionally important spectrin-actin binding domain, as well as higher molecular weight species with extended NH2 termini that initiate translation within an alternatively spliced upstream exon. We are exploring the hypothesis that differentiation-associated switches in protein 4.1 structure play an important role in the membrane reorganization that accompanies erythroid terminal differentiation.
To study changes in 4.1 gene expression during normal human differentiation, we analyzed 4.1 protein and mRNA structure at various developmental stages. Using immunofluorescence microscopy, we observed high molecular weight 4.1 isoforms in preproerythroblasts producing punctate, cytoplasmic staining with a perinuclear area of intense fluorescence, while mature red cells expressed very little high molecular weight 4 Cells. Preproerythroblasts were obtained from normal human bone marrow by negative selection using an avidin-biotin immune rosetting technique as previously described (21) . In brief, after informed consent, bone marrow was obtained at the time of hip replacement surgery and the low-density mononuclear cells collected by Ficoll-Hypaque (1.077 g/cm3) (Eurobio, Paris, France) separation. Plastic adherent cells were removed by incubation in 75 cm2 flasks for 1 h at 37°C. The nonadherent mononuclear cells (0.5-3 x 108) were depleted of mature granulocytes by pelleting out granulocytes which had phagocytozed sheep red blood cells coupled to avidin. The remaining cells (4 x 107 cells/ml) were then incubated with an excess of the following monoclonal antibodies: OKla, CALLA, CS4, B 1, K5, HPCA, CH3, CK26, NKH-1, Leu 4, and Leu Sb, antibodies to lineage-specific antigens on CFU-GM, myeloid precursors, T and B cells, macrophages, monocytes, red cells, and platelets. The antibody-coated cells were removed by centrifugation after rosetting with biotin-conjugated goat anti-mouse IgM and IgG and sheep red blood cells conjugated to avidin. The nonrosetting cells were recovered and characterized by immunophenotyping, electron microscopy, and by their ability to form colonies on methylcellulose colony assays. On the basis of this characterization, the purified population was 80-90% erythroid and the distribution within the purified erythroid population was 15% colony forming unit-erythroid, 75% preproerythroblasts, and 10% proerythroblast.
Pure populations of differentiated erythroblasts (> 90% purity) were obtained by plucking individual erythroid colonies derived from primitive normal marrow burst forming unit-erythroid (BFU-E) grown 5, 8, 12 , and 14 d in methylcellulose colony assays in the presence of erythropoietin and leukocyte-conditioned medium as previously described (21 (24) . RNA from preproerythroblasts and BFU-Ederived erythroblasts was prepared using the method of Laski and colleagues (25 Expression of isoforms with NH2-terminal extension. For these studies, we prepared affinity-purified antibodies to two synthetic peptides: a 20-amino acid peptide that is unique for the amino terminal extension (residues 96-115); and a 34-amino acid peptide from the alternatively expressed 102-nt exon in the 22-24 kD carboxy-terminal region (Fig. 1) . The presence or absence of the alternatively expressed protein sequences during erythroid differentiation was initially evaluated by performing immunofluorescence microscopy on mature red cells and erythroid progenitors isolated from human bone marrow (Fig. 2 A) . Very immature erythroid precursors in the preproerythroblast stage of maturation were obtained by negative selection using an avidin-biotin immune rosetting technique. When these cell populations were examined with antibody to the 34-amino acid insert within the 22-24-kD domain (anti 24-2), a punctate distribution of fluorescence was present in the preproerythroblast, while intense membrane-associated fluorescence was observed in mature red cells (Fig. 3) . When preproerythroblasts were probed with antibody to the isoform characterized by an elongated amino terminus (anti N-1) there was punctate, predominantly cytoplasmic, fluorescence with an area of intense fluorescence apparently adjacent to the nucleus (Fig. 3) . However, no fluorescence was observed in mature red cells examined with this antibody. Thus, isoforms con- taining the 34-amino acid insert were present in both preproerythroblasts and mature red cells, while isoforms containing the amino terminal extension were abundant in preproerythroblasts but not in mature red cells. Moreover, the cellular localization of the anti N-1 staining isoforms appeared different from that of the anti 24-2 staining isoforms. To characterize 4.1 isoform expression in greater detail, erythroblasts at multiple time points during erythropoiesis were examined by immunofluorescence microscopy and Western blot analysis. BFU-E-derived erythroblasts, cultured for 5 and 8 d and probed with antibody 24-2, demonstrated staining similar to that observed in the preproerythroblasts with a diffuse punctate pattern that was predominantly cytoplasmic (Fig. 4 b and c) . To determine whether the absence of protein 4.1 on the plasma membrane of these erythroblasts could be caused by lack of membrane assembly of spectrin, the cells were probed with an antibody to a-spectrin. As shown in Fig. 4 h and i, plasma membrane associated fluorescence was already present in erythroblasts cultured for 5 d implying that by day 5, spectrin was assembled on the plasma membrane and suggesting that the lack of membrane assembly of 4.1 isoforms could not be attributed to the absence of spectrin. With antibody N-I staining, BFU-E derived erythroblasts cultured for 5 d contained a body of intense fluorescence similar to that observed in the preproerythroblasts (Figs. 3 b and 4 e) . To study the relationship of this fluorescent body to the nucleus, nuclear staining with propidium iodide was performed. As shown in Fig. 4 d, the region ofintense anti N-1 staining clearly localized to the cytoplasm. To determine whether there was a differentiation-associated change in expression of isoforms containing the amino-terminal extension, 8-d erythroblasts were probed with anti N-1. In contrast to preproerythroblasts and 5-d erythroblasts, the 8-d progenitors did not contain any cytoplasmic region ofintense fluorescence (Fig. 4J) . These immunofluorescent data clearly show that protein 4.1 isoforms are differentially expressed during erythropoiesis. Furthermore, the observed differences in cellular localization of the 4.1 isoforms suggest multiple functions for this protein family during erythroid differentiation.
Immunoblotting was performed to further analyze the structure of the protein 4.1 isoforms containing the alterna- tively expressed peptides (Fig. 5) . Four To characterize alternative splicing events within the coding domain of the 80-kD protein that occur during terminal erythroid differentiation, we performed reverse transcriptase/PCR assays. Using six pairs of oligonucleotide primers that spanned the entire coding domain of the 80-kD polypeptide, we amplified cDNA from four erythroid maturational stages by PCR. The RNA for these studies was prepared from preproerythroblasts, BFU-E-derived erythroblasts cultured for 8 and 12 d and reticulocytes. cDNAs were transcribed from RNA, then amplified by polymerase chain reaction, and analyzed on polyacrylamide gels (Fig. 6) To analyze in greater detail the differentiation-associated splicing switch involving the spectrin-actin binding domain, we quantitated the percentage of +63 and -63 mRNA species using nuclease protection assays. For these studies, a fragment of DNA containing the 63-bp exon was inserted into Bluescript plasmid and antisense RNA probes synthesized. In this assay system, antisense mRNA containing the 63-nucleotide exon will generate a single large fragment upon hybridization to mRNA containing this exon (+63 phenotype). mRNA that lacks the 63-nucleotide exon will generate two smaller protected fragments, as seen in the MOLT-4 lymphoblast RNA control (-63 phenotype). In preproerythroblasts -99% of the protected fragment was -63, in BFU-E-derived erythroblasts about 50% was -63 and 50% was +63, and in reticulocytes > 99% was +63 (Fig. 7) . These data imply that the splicing switch from the -63 species to the +63 species occurs late in erythropoiesis as the cells differentiate into polychromatophilic and acidophilic erythroblasts. From the PCR and nuclease protection assays, we conclude that during erythroid differentiation, the splicing pattern of the glycophorin binding domain is invariant, while that of the spectrin-actin binding domain varies.
To characterize the expression of protein 4.1 isoforms containing the spectrin-actin binding domain encoded by the 63-nucleotide exon, immunoblotting was performed. Protein from equivalent numbers of 12-, 13-, and 14-day BFU-E-derived erythroblasts was probed with an antipeptide antibody to the 21 amino acids encoded by the 63-nucleotide exon. As shown in Fig. 8 , the expression of an isoform containing the spectrin-actin binding domain increased as the erythroid progenitors progressed along the differentiation pathway. 
Discussion
Dramatic contrasts exist between circulating, nonadherent erythrocytes and their adherent progenitors within the bone marrow. To traverse the microcirculation, a mature erythrocyte must undergo repeated and extensive passive deformation, requiring a highly deformable membrane. In addition, the mature cell membrane must be both mechanically stable, so that the cell can resist fragmentating under normal circulatory fluid stresses, and also possess a distribution of negative charge and surface component characteristics that render it nonadherent. In contrast, the functional requirements of the plasma membrane of the committed erythroid progenitor are vastly different. These progenitors engage in cell-cell and cell-extracellular matrix adhesion through expression of receptors for matrix components, such as the fibronectin receptors, VLA-4 and VLA-5, and a sialyated macrophage receptor (27) (28) (29) (30) (31) (32) . In addition, the progenitor membrane facilitates endocytosis with, for example, transferrin receptor recycling (33-35), while the membrane of mature red cells does not undergo extensive receptor-mediated endocytosis.
A wealth of evidence has accumulated from studies of pathologic erythrocytes and biochemically perturbed normal red cells indicating that membrane properties of deformability and mechanical stability are regulated by skeletal protein organization (8) (9) (10) . In previous studies, we observed that membranes ofimmature reticulocytes in the stage immediately after nuclear extrusion were tenfold less deformable and mechanically stable than mature erythroid membranes, but that during the period of reticulocyte maturation, there was a marked increase in membrane deformability and acquisition ofmechanical stability (7) . These observed changes in membrane properties imply extensive membrane reorganization during reticulocyte maturation. We hypothesize that changes in skeletal protein expression may play a critical role in the membrane reorganization that accompanies erythroid terminal differentiation. This process of reorganization could involve either quantitative and/or qualitative changes in skeletal protein components.
In this study, we have clearly documented a qualitative change in expression of a skeletal protein during erythropoiesis by showing two differentiation-associated switches in 4. (36) . Although the function of the NH2-terminal domain is not yet well characterized, our immunofluorescent data suggest that 4.1 isoforms containing this domain do not localize to the plasma membrane, and it therefore seems unlikely that these isoforms provide structural integrity to the membrane. Marchesi and colleagues have performed immunofluorescence in lymphocytes with a recombinant fusion protein in Escherichia coli that expresses the NH2-terminal extension (37) . They observed interactions of this fusion protein with intranuclear structures, including centrioles and midbodies, and conclude that the protein plays a role in the mitotic process. We speculate that the intense area of fluorescence in preproerythroblasts may be localized to the centriole that is present in the perinuclear area in preproerythroblasts (38) . This cellular localization also suggests a role for the high molecular weight isoforms of 4.1 in mitosis.
The second switch in 4.1 gene expression involves the functionally important spectrin-actin binding domain. Preproerythroblasts and BFU-E-derived erythroblasts cultured for 8 d express little of the 63-nt exon within this domain. However, expression of the 63-nt exon is activated during differentiation with 12-d erythroblast mRNA composed of 50% +63 species and 50% -63 species. Once the activation has occurred increasing quantities of expressed protein can be demonstrated by immunoblotting in 12-, 13-, and 14-d erythroblasts. Thus, expression of a 4.1 isoform with an intact spectrin-actin binding domain appears to be a very late event during erythropoiesis. This functional binding domain mediates the formation ofthe structurally important ternary complex of spectrin, actin and protein 4.1. Biochemical conditions that inhibit the formation of the ternary complex result in alterations in membrane mechanical properties. For example, red cells from certain patients with hereditary spherocytosis contain a mutant spectrin that leads to decreased spectrin-4.1 binding, and decreased membrane mechanical stability (39) . Similarly, abnormal stability is observed in normal red cells treated with 2,3-diphosphoglyceric acid, a polyphosphate known to dissociate the spectrin-actin-4.1 complex (10). In addition, deletion of the spectrin-actin binding domain in protein 4 (17, 20) . Since induced MEL cells exhibit ultrastructural abnormalities and do not express normal amounts of either hemoglobin or membrane proteins (41), we believe that protein synthesis and membrane assembly may not be entirely analogous in induced MEL cells and normally differentiating human erythroid progenitors, and that it is crucial to study the biology ofhuman erythropoiesis using normal human erythroid progenitors rather than transformed mouse cell lines.
Interestingly, our analysis of 80-kD 4.1 mRNA species revealed no differentiation-associated splicing switches other than that involving the spectrin-actin binding domain. These data suggest that a second, important functional domain, the glycophorin binding domain, is invariantly expressed from the preproerythroblast through the reticulocyte stage of maturation. Glycophorin C, an integral membrane protein, appears to associate with 4.1 through its cytoplasmic tail. Although no direct binding studies have yet been done to characterize this interaction and define the amino acids included in the binding site, strong indirect evidence exists, suggesting that a functionally important 4.1 -glycophorin C interaction indeed occurs. Specifically, elliptocytic red cells deficient in 4.1 because of a primary mutation in the 4.1 gene are secondarily deficient in glycophorin C (14) . Further, membrane skeletons prepared with Triton X-100 from 4. 1-deficient cells lack glycophorin C, while skeletons prepared from 4. 1-deficient cells that had been reconstituted with normal 4.1 retain glycophorin C (1 3, 14) . In support of the functional role of this protein-protein interaction are the observations that glycophorin C-deficient red cells (Leach phenotype) have membrane instability and abnormal morphology (42) . During terminal erythroid differentiation, glycophorin C is first expressed on the surface at the colony forming unit-erythrocyte stage, a maturational stage before the preproerythroblast (43) . This finding suggests that the 4.1 isoform(s) anchoring glycophorin C within the lipid bilayer is also expressed at an early stage of erythropoiesis and is consistent with our observations showing the invariant expression of the glycophorin binding domain from the preproerythroblasts through the reticulocyte stage of maturation.
We believe that dynamic reorganization of the membrane skeleton occurs during terminal erythroid differentiation resulting in membranes with markedly different functional and mechanical characteristics. While previous studies have described the sequential synthesis and assembly of various skeletal proteins during erythropoiesis (1-4), our current studies show that there is also differential expression of 4.1 isoforms during erythroid maturation. Recently, other structural proteins of the erythroid membrane, such as ankyrin and protein 4.2, have also been shown to undergo alternative splicing so that they are also potential candidates for differentiation-associated switches in gene expression. Our findings that switches in protein 4.1 gene expression occur during erythropoiesis represent one potentially important mechanism for membrane skeletal reorganization. Ahead lies the challenge of defining specific functions of 4.1 isoforms during erythropoiesis and of determining the molecular mechanisms that trigger the switch in 4.1 gene expression.
